MONTRÉAL--(BUSINESS WIRE)--Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., welcomes the recently announced public formulary coverage for AJOVY ® (fremanezumab) by Ontario, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback